TLRY Stock Analysis: Buy, Sell, or Hold?
TLRY - Tilray Brands, Inc. Common Stock
$4.73
-0.02 (-0.42%)
▼
5d:
-7.62%
30d:
-9.21%
90d:
-28.98%
HOLD
LOW Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Jul 27, 2026
Smart Money Accumulation
None View Scanner →
Strength: 10.0/10
Get Alerted When TLRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TLRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: TLRY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: TLRY is currently trading at $4.73, which is considered oversold relative to its 30-day fair value range of $4.99 to $5.49. From a valuation perspective, the stock is trading at a discount (Forward PE: -14.2) compared to its historical average (201.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TLRY is in a strong downtrend. The price is currently testing key support at $4.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TLRY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.04 (+112.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TLRY is in a strong downtrend. The price is currently testing key support at $4.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: TLRY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.04 (+112.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.99 -
$5.49
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
Protect Your Profits
Holding TLRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 112.4% below Wall St target ($10.04)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Recommendation downgraded due to -7.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$4.99 -
$5.49
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.63
Resistance Level
$5.48
Current Trend
Strong Downtrend
Technical data as of
Jun 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.21
Wall Street Target
$10.04
(+112.4%)
Revenue Growth (YoY)
-7.8%
Profit Margin
-156.7%
PE vs Historical
-14.2 vs 201.6
CHEAP
Share & Embed Analysis
Last updated: June 19, 2026 8:29 PM ET
Data refreshes hourly during market hours. Next update: 9:29 PM
Data refreshes hourly during market hours. Next update: 9:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
David G Hopkinson
SELL
33556 shares
2026-04-21
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 58 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 60 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 58 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 67 BUY |
Advanced TLRY Option Strategies
Professional options setups generated by AI based on today's TLRY price and gamma walls.
